Clinical trials
Completed Phase 2 Liver Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 5 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| Mirum Pharmaceuticals, Inc. | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Ocera Therapeutics | 2 |
| Sagimet Biosciences Inc. | 2 |
| 89bio, Inc. | 1 |
| Akcea Therapeutics | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Aligos Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Diseases | 48 |
| Non-alcoholic Fatty Liver Disease | 13 |
| Hepatitis C | 11 |
| Digestive System Diseases | 8 |
| Fatty Liver | 8 |
| Fibrosis | 7 |
| Hepatitis C, Chronic | 6 |
| Hepatitis | 5 |
| Virus Diseases | 5 |
| Hepatitis, Chronic | 4 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.